TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 5 | 7 | 5 | 8 | 44 | 12 |
| S | %wins | 67 | 33 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/25/24 16:44 | 10/25/24 | INGM | Ingram Micro Holding Corp | DE | Electr | WhElc | Computers & Peripheral Equipm | Sherman Scott D | CA | O | EVP,HR | P | 200 | 22.00 | 0 | 9 | 5 | 207 | D | ||||||||||||||
4/23/14 19:25 | 4/21/14 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Sherman Scott D | CA | O | EVP,HR | M.dm | 1,084 | 74.79 | 33 | 15 | 10 | D | 204 | 110 | 40 | 11 | -2 | -2 | 8 | 3 | 0 | -3 | 2 | 6 | 11 | 45 | |
4/23/14 19:25 | 4/21/14 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Sherman Scott D | CA | O | EVP,HR | S.dm | -2,259 | 155.82 | 33 | -15 | -60 | 10 | D | 204 | 110 | 40 | 11 | -2 | -2 | 8 | 3 | 0 | -3 | 2 | 6 | 11 | 45 |
2/19/14 14:44 | 2/14/14 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Sherman Scott D | CA | O | EVP,HR | S.dm | -629 | 125.74 | 33 | -5 | -35 | 9 | D | 235 | 136 | 50 | 23 | 20 | 9 | 10 | 6 | 4 | 12 | 7 | 4 | 8 | 41 |
2/19/14 14:44 | 2/18/14 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Sherman Scott D | CA | O | EVP,HR | M.d | 378 | 75.58 | 33 | 5 | 112 | 9 | D | 235 | 136 | 50 | 23 | 20 | 9 | 10 | 6 | 4 | 12 | 7 | 4 | 8 | 41 |
2/11/14 20:41 | 2/7/14 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Sherman Scott D | CA | O | EVP,HR | M.dm | 707 | 74.38 | 33 | 10 | 999% | 10 | D | 227 | 116 | 41 | 22 | 14 | 2 | 1 | 3 | -1 | 5 | 11 | 6 | 6 | 47 |
2/11/14 20:41 | 2/7/14 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Sherman Scott D | CA | O | EVP,HR | S.dm | -1,133 | 119.31 | 33 | -10 | -50 | 10 | D | 227 | 116 | 41 | 22 | 14 | 2 | 1 | 3 | -1 | 5 | 11 | 6 | 6 | 47 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |